Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-011869

Director acquired 454 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2024-06-13 Other acquisition 10b5-1 +25 $1.52 $38 33,432 D
Jones James Director 2024-06-14 Other acquisition 10b5-1 +48 $1.50 $72 33,480 D
Jones James Director 2024-06-17 Other acquisition 10b5-1 +41 $1.49 $61 33,521 D
Jones James Director 2024-06-18 Other acquisition 10b5-1 +41 $1.57 $64 33,562 D
Jones James Director 2024-06-20 Other acquisition 10b5-1 +41 $1.53 $63 33,603 D
Jones James Director 2024-06-21 Other acquisition 10b5-1 +41 $1.49 $61 33,644 D
Jones James Director 2024-06-24 Other acquisition 10b5-1 +44 $1.59 $70 33,688 D
Jones James Director 2024-06-25 Other acquisition 10b5-1 +44 $1.54 $68 33,732 D
Jones James Director 2024-06-26 Other acquisition 10b5-1 +44 $1.50 $66 33,776 D
Jones James Director 2024-06-27 Other acquisition 10b5-1 +44 $1.52 $67 33,820 D
Jones James Director 2024-06-28 Other acquisition 10b5-1 +41 $1.50 $62 33,861 D
Loading xslF345X05/marketforms-66486.xml…